메뉴 건너뛰기
Cleveland Clinic Journal of Medicine
Volumn 64, Issue 8, 1997, Pages 410-413
Is intensive glycemic control worth the expense?
Author keywords

[No Author keywords available]
Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD; COST BENEFIT ANALYSIS; ECONOMICS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; UNITED STATES;
EID: 0031225429     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.64.8.410     Document Type: Article
Times cited : (7)
References (7)
  • 1
    • 0027370108 scopus 로고
    • The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
    • The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
    • (1993) N Engl J Med , vol.329 , pp. 977-986
  • 2
    • 0029908290 scopus 로고    scopus 로고
    • Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial
    • The Diabetes Control and Complications Trial Research Group. Lifetime benefits and costs of intensive therapy as practiced in the Diabetes Control and Complications Trial. JAMA 1996; 276:1409-1415.
    • (1996) JAMA , vol.276 , pp. 1409-1415
  • 3
    • 0028944962 scopus 로고
    • Hyperglycemia and microvascular and macrovascular disease in diabetes
    • Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18:258-268.
    • (1995) Diabetes Care , vol.18 , pp. 258-268
    • Klein, R.1
  • 4
    • 0029147687 scopus 로고    scopus 로고
    • Intensive insulin therapy prevents progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
    • Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1996; 28:103-117.
    • (1996) Diabetes Res Clin Pract , vol.28 , pp. 103-117
    • Ohkubo, Y.1    Kishikawa, H.2    Araki, E.3
  • 5
    • 15444346214 scopus 로고    scopus 로고
    • Model of complications of NIDDM: I. Model construction and assumptions
    • Eastman, RC, Javitt JC, Herman, WH, et al. Model of complications of NIDDM: I. Model construction and assumptions. Diabetes Care 1997; 20:725-734.
    • (1997) Diabetes Care , vol.20 , pp. 725-734
    • Eastman, R.C.1    Javitt, J.C.2    Herman, W.H.3
  • 6
    • 15644366137 scopus 로고    scopus 로고
    • Model of complications of NIDDM: II. Analysis of the health benefits and cost-effectivenss of treating NIDDM with the goal of normoglycemia
    • Eastman, RC, Javitt JC, Herman, WH, et al. Model of complications of NIDDM: II. Analysis of the health benefits and cost-effectivenss of treating NIDDM with the goal of normoglycemia. Diabetes Care 1997; 20:735-744.
    • (1997) Diabetes Care , vol.20 , pp. 735-744
    • Eastman, R.C.1    Javitt, J.C.2    Herman, W.H.3
  • 7
    • 0006179936 scopus 로고    scopus 로고
    • Health economic benefits of improved glycemic control in NIDDM
    • Testa M, Simonson D. Health economic benefits of improved glycemic control in NIDDM. Diabetes 1997; 46(Suppl 1):36A.
    • (1997) Diabetes , vol.46 , Issue.1 SUPPL.
    • Testa, M.1    Simonson, D.2

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.